Validation and calibration of the patient health questionnaire (PHQ-9) in Argentina
Tóm tắt
The Patient Health Questionnaire-9 (PHQ-9) is a brief tool to assess the presence and severity of depressive symptoms. This study aimed to validate and calibrate the PHQ-9 to determine appropriate cut-off points for different degrees of severity of depression in Argentina.
We conducted a cross-sectional study on an intentional sample of adult ambulatory care patients with different degrees of severity of depression. All patients who completed the PHQ-9 were further interviewed by a trained clinician with the Mini International Neuropsychiatric Interview (MINI) and the Beck Depression Inventory-II (BDI-II). Reliability and validity tests, including receiver operating curve analysis, were performed.
One hundred sixty-nine patients were recruited with a mean age of 47.4 years (SD = 14.8), of whom 102 were females (60.4%). The local PHQ-9 had high internal consistency (Cronbach’s alpha = 0.87) and satisfactory convergent validity with the BDI-II scale [Pearson’s correlation = 0.88 (
The Argentine version of the PHQ-9 questionnaire has shown acceptable validity and reliability for both screening and severity assessment of depressive symptoms.
Từ khóa
Tài liệu tham khảo
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57.
Marcus M, Taghi M, Van Ommeren M, Chisholm D, Saxena S. In: Abuse WDMHS, editor. Depression: a global public health concern in. Mental Health, Disorders Management: World Health Organization; 2012.
Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365–72.
Jiang W, Kuchibhatla M, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR, O'Connor CM. Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J. 2007;154(1):102–8.
Gerontoukou EI, Michaelidoy S, Rekleiti M, Saridi M, Souliotis K. Investigation of anxiety and depression in patients with chronic diseases. Health Psychol Res. 2015;3(2):2123.
Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. JAMA : the journal of the American Medical Association. 2004;291(21):2581–90.
Kohn R, Levav I, de Almeida JM, Vicente B, Andrade L, Caraveo-Anduaga JJ, Saxena S, Saraceno B. Mental disorders in Latin America and the Caribbean: a public health priority. Revista panamericana de salud publica = Pan American journal of public health. 2005;18(4–5):229–40.
Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, Aboyans V, Abraham JP, Abubakar I, Abu-Raddad LJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–91.
Patel V, Araya R, Bolton P. Treating depression in the developing world. Tropical medicine & international health : TM & IH. 2004;9(5):539–41.
Ormel J, Petukhova M, Chatterji S, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Bromet EJ, Burger H, Demyttenaere K, de Girolamo G, et al. Disability and treatment of specific mental and physical disorders across the world. The British journal of psychiatry : the journal of mental science. 2008;192(5):368–75.
Wang PS, Angermeyer M, Borges G, Bruffaerts R, Tat Chiu W, G DEG, Fayyad J, Gureje O, Haro JM, Huang Y, et al. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's world mental health survey initiative. World psychiatry : official journal of the World Psychiatric Association (WPA). 2007;6(3):177–85.
McDowell I. Measuring health: a guide to rating scales and questionnaire. In. New York: OXFORD UNIVERSITY PRESS; 2006.
Kroenke K, Spitzer RL, Williams JB, Lowe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–59.
Kung S, Alarcon RD, Williams MD, Poppe KA, Jo Moore M, Frye MA. Comparing the Beck depression inventory-II (BDI-II) and patient health questionnaire (PHQ-9) depression measures in an integrated mood disorders practice. J Affect Disord. 2013;145(3):341–3.
Michal M, Wiltink J, Lackner K, Wild PS, Zwiener I, Blettner M, Munzel T, Schulz A, Kirschner Y, Beutel ME. Association of hypertension with depression in the community: results from the Gutenberg health study. J Hypertens. 2013;31(5):893–9.
van Dooren FE, Denollet J, Verhey FR, Stehouwer CD, Sep SJ, Henry RM, Kremers SP, Dagnelie PC, Schaper NC, van der Kallen CJ, et al. Psychological and personality factors in type 2 diabetes mellitus, presenting the rationale and exploratory results from the Maastricht study, a population-based cohort study. BMC psychiatry. 2016;16(1):17.
Elperin DT, Pelter MA, Deamer RL, Burchette RJ. A large cohort study evaluating risk factors associated with uncontrolled hypertension. J Clin Hypertens (Greenwich). 2014;16(2):149–54.
Tracy M, Morgenstern H, Zivin K, Aiello AE, Galea S. Traumatic event exposure and depression severity over time: results from a prospective cohort study in an urban area. Soc Psychiatry Psychiatr Epidemiol. 2014;49(11):1769–82.
Kiely KM, Butterworth P. Validation of four measures of mental health against depression and generalized anxiety in a community based sample. Psychiatry Res. 2015;225(3):291–8.
Haddad M, Walters P, Phillips R, Tsakok J, Williams P, Mann A, Tylee A. Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in primary care, findings from the UPBEAT-UK study. PLoS One. 2013;8(10):e78493.
Zimmerman M, Martinez JH, Friedman M, Boerescu DA, Attiullah N, Toba C. Speaking a more consistent language when discussing severe depression: a calibration study of 3 self-report measures of depressive symptoms. J Clin Psychiatry. 2014;75(2):141–6.
Kendrick T, Dowrick C, McBride A, Howe A, Clarke P, Maisey S, Moore M, Smith PW. Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. BMJ. 2009;338:b750.
Bonicatto SG, P; Tutor, C; Lucero, S; Güenaga, F; Torino, D.: Screening of mental disorders in primary care: linguistic adaptation procedure of a diagnostic instrument. In., vol. 45(3): Acta psiquiátr. psicol. Am. Lat; 1999: 223–234.
Kroenke K, Spitzer R. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32:509–15.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
Ferrando L, Bobes J, Gibert J. In: Sheehan DV, Lecrubier Y, editors. M.I.N.I: Mini international neuropsychiatric interview version en español 5.0.0. Copyright 1992–2004. Spain: University of South Florida, Tampa. Instituto IAP – Madrid – Spain; 2000.
First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1995.
Sheehan D, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E, Bonora L, Keskiner A, Schinka J, Knapp E, Sheehan M, et al. Reliability and validity of the MINI international neuropsychiatric interview (MINI): according to the SCID-P. Eur Psychiatry. 1997;12:232–41.
Brenlla M, Rodríguez C: Adaptación argentina del Inventario de Depresión de Beck (BDI-II). BDI-II Inventario de Depresión de Beck Segunda Edición Manual Buenos Aires: Paidós[Links] 2006.
Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric evaluation of the Beck depression inventory-II with primary care medical patients. Health Psychol. 2001;20(2):112–9.
Grothe KB, Dutton GR, Jones GN, Bodenlos J, Ancona M, Brantley PJ. Validation of the Beck depression inventory-II in a low-income African American sample of medical outpatients. Psychol Assess. 2005;17(1):110–4.
Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839–43.
Huang CQ, Dong BR, Lu ZC, Yue JR, Liu QX. Chronic diseases and risk for depression in old age: a meta-analysis of published literature. Ageing Res Rev. 2010;9(2):131–41.
Lotrakul M, Sumrithe S, Saipanish R. Reliability and validity of the Thai version of the PHQ-9. BMC psychiatry. 2008;8:46.
Liu SI, Yeh ZT, Huang HC, Sun FJ, Tjung JJ, Hwang LC, Shih YH, Yeh AW. Validation of patient health questionnaire for depression screening among primary care patients in Taiwan. Compr Psychiatry. 2011;52(1):96–101.
Chen S, Fang Y, Chiu H, Fan H, Jin T, Conwell Y. Validation of the nine-item patient health questionnaire to screen for major depression in a Chinese primary care population. Asia Pac Psychiatry. 2013;5(2):61–8.
Baader MT, Molina FJL, Venezian BS, Rojas CC, Farías SR, Fierro-Freixenet C, Backenstrass M, Mundt C. Validación y utilidad de la encuesta PHQ-9 (Patient Health Questionnaire) en el diagnóstico de depresión en pacientes usuarios de atención primaria en Chile. Revista chilena de neuro-psiquiatría. 2012;50:10–22.
Chagas MH, Tumas V, Rodrigues GR, Machado-de-Sousa JP, Filho AS, Hallak JE, Crippa JA. Validation and internal consistency of patient health Questionnaire-9 for major depression in Parkinson's disease. Age Ageing. 2013;42(5):645–9.
Patten SB, Burton JM, Fiest KM, Wiebe S, Bulloch AG, Koch M, Dobson KS, Metz LM, Maxwell CJ, Jette N. Validity of four screening scales for major depression in MS. Mult Scler. 2015.
Munoz-Navarro R, Cano-Vindel A, Medrano LA, Schmitz F, Ruiz-Rodriguez P, Abellan-Maeso C, et al. Utility of the PHQ-9 to identify major depressive disorder in adult patients in Spanish primary care centres. BMC psychiatry. 2017;17(1):291.
Milette K, Hudson M, Baron M, Thombs BD. Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. Rheumatology (Oxford). 2010;49(4):789–96.
Rogers WH, Adler DA, Bungay KM, Wilson IB. Depression screening instruments made good severity measures in a cross-sectional analysis. J Clin Epidemiol. 2005;58(4):370–7.
Kneipp SM, Kairalla JA, Stacciarini JM, Pereira D, Miller MD. Comparison of depressive symptom severity scores in low-income women. Nurs Res. 2010;59(6):380–8.
Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL. Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosom Med. 2001;63(4):679–86.
Dum M, Pickren J, Sobell LC, Sobell MB. Comparing the BDI-II and the PHQ-9 with outpatient substance abusers. Addict Behav. 2008;33(2):381–7.
Adewuya AO, Ola BA, Afolabi OO. Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students. J Affect Disord. 2006;96(1–2):89–93.
Huang FY, Chung H, Kroenke K, Delucchi KL, Spitzer RL. Using the patient health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med. 2006;21(6):547–52.
Hepner KA, Hunter SB, Edelen MO, Zhou AJ, Watkins K. A comparison of two depressive symptomatology measures in residential substance abuse treatment clients. J Subst Abus Treat. 2009;37(3):318–25.
Lai BP, Tang AK, Lee DT, Yip AS, Chung TK. Detecting postnatal depression in Chinese men: a comparison of three instruments. Psychiatry Res. 2010;180(2–3):80–5.
Streiner DL, Cairney J. What's under the ROC? An introduction to receiver operating characteristics curves. Can J Psychiatry. 2007;52(2):121–8.
Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the patient health questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med. 2007;22(11):1596–602.